Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07613918 · ClinicalTrials.gov registry record

Brain Blood Flow and Cerebral Autoregulation Monitoring in Critically Ill Children

A clinical trial, sponsored by University of Wisconsin, Madison.

Not yet
Registry status
125
Enrollment target

NCT07613918 is a clinical trial that has not yet begun recruiting, run by University of Wisconsin, Madison. The registered enrollment target is 125 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07613918 has not yet begun recruiting, sponsored by University of Wisconsin, Madison.

NOT YET RECRUITING
Registry status
125 participants
Enrollment target

Study Summary

This study uses a non-invasive (external) ultrasound test called Transcranial Doppler (TCD) to measure how blood flows through the major arteries of the brain of children receiving care in the Pediatric Intensive Care Unit (PICU). TCD is already used for clinical reasons in many children, but it is not part of routine monitoring for every critically ill child. By using TCD, the investigators hope to better understand how brain blood flow changes during illness. They will also track children's functional status from before their illness to the time of PICU discharge to explore how brain blood flow patterns relate to neurological outcomes.125 participants will be enrolled and will be on study while in the PICU, estimated to be 3-14 days.

Interventions

  • DEVICE Transcranial Doppler

Trial Details

FieldValue
Enrollment Target 125 participants
Start Date 2026-07
Est. Completion 2028-05

Sponsor

University of Wisconsin, Madison

1,039 total trials

What the Registry Record Tells You About NCT07613918

The ClinicalTrials.gov registry entry for NCT07613918 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Transcranial Doppler is the first listed.

NCT07613918 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07613918 about?

NCT07613918 is a clinical study titled "Brain Blood Flow and Cerebral Autoregulation Monitoring in Critically Ill Children". This study uses a non-invasive (external) ultrasound test called Transcranial Doppler (TCD) to measure how blood flows through the major arteries of the brain of children receiving care in the Pediatric Intensive Care Unit (PICU). TCD is already used for clinical reasons in many children, but it is ...

What is the current status of trial NCT07613918?

This trial is currently not yet recruiting. The enrollment target is 125 participants. The study started on 2026-07. Estimated completion is 2028-05.

What interventions are being tested in trial NCT07613918?

The interventions under investigation include: Transcranial Doppler (DEVICE).

Who is sponsoring clinical trial NCT07613918?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.